{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:55:25Z","timestamp":1777424125062,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jfo.2016.01.008","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T10:57:21Z","timestamp":1464087441000},"page":"535-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Traitement par \u00e9pl\u00e9r\u00e9none dans la chorior\u00e9tinite s\u00e9reuse centrale chronique"],"prefix":"10.1016","volume":"39","author":[{"given":"M.","family":"Sampo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gascon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ho Wang Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hoffart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Matonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2016.01.008_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","article-title":"Diagnosis and interventions for central serous chorioretinopathy: review and update","volume":"41","author":"Quin","year":"2013","journal-title":"Clin Experiment Ophtalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0125","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","article-title":"Enhanced depth imaging spectral-domain optical coherence tomography","volume":"146","author":"Spaide","year":"2008","journal-title":"Am J ophtalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0130","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2016.01.008_bib0135","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion ans water channels in M\u00fcller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.jfo.2016.01.008_bib0140","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfo.2016.01.008_bib0145","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.72.11.829","article-title":"Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous chorioretinopathy","volume":"72","author":"Ficker","year":"1988","journal-title":"Br J Ophtalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10384-012-0138-3","article-title":"Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathy","volume":"56","author":"Nomura","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0155","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophtalmolgy"},{"key":"10.1016\/j.jfo.2016.01.008_bib0160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","article-title":"Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial","volume":"121","author":"Bae","year":"2014","journal-title":"Ophtalmology"},{"key":"10.1016\/j.jfo.2016.01.008_bib0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bjophthalmol-2011-300183","article-title":"Oral rifampcin utilisation for the treatment of chronic multifocal central serous chorioretinopathy","volume":"96","author":"Steinle","year":"2012","journal-title":"Br J Ophtalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0170","article-title":"Oral rifampin treatment for longstanding chronic central serous chorioretinopathy","author":"Shulman","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol 2015"},{"key":"10.1016\/j.jfo.2016.01.008_bib0175","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/IAE.0b013e318050ca69","article-title":"Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy","volume":"27","author":"Meyerle","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2016.01.008_bib0180","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1755-3768.2008.01467.x","article-title":"Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study","volume":"88","author":"Golshahi","year":"2010","journal-title":"Acta Ophtalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0185","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/IAE.0b013e31821c3ef6","article-title":"Oral mifepristone for chronic central serous chorioretinopathy","volume":"31","author":"Nielsen","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2016.01.008_bib0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/bjo.2006.098277","article-title":"The potential role of testosterone in central serous chorioretinopathy","volume":"91","author":"Grieshaber","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0195","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/IAE.0b013e3181f04a35","article-title":"Finasteride for chronic central serous chorioretinopathy","volume":"31","author":"Forooghian","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2016.01.008_bib0200","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfo.2016.01.008_bib0205","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for non resolving central serous chorioretinopathy: a randomized controlled crossover study","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2016.01.008_bib0210","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2016.01.008_bib0215","first-page":"e488","article-title":"The use of eplerenone in therapy-resistant chornic central serous chorioretinopathy","volume":"92","author":"Breuking","year":"2014","journal-title":"Acta Ophtalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0220","first-page":"310","article-title":"Oral eplerenone for the management of chronic central serous chorioretinopathy","volume":"8","author":"Singh","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.01.008_bib0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3928\/23258160-20150422-06","article-title":"Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series","volume":"46","author":"Salz","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jfo.2016.01.008_bib0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Experiment Ophtalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551216300675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551216300675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:06:33Z","timestamp":1759259193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551216300675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0181551216300675"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2016.01.008","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement par \u00e9pl\u00e9r\u00e9none dans la chorior\u00e9tinite s\u00e9reuse centrale chronique","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2016.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}